SCHEMBL5873483

SCHEMBL5873483

COC(=O)c1cc(N2CC3CCC2C3)nc2ccc([N+](=O)[O-])cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
HTT P42858 1/20 0.42
KDM4E B2RXH2 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
F2 P00734 1/20 0.39
PLAU P00749 1/20 0.39
KLKB1 P03952 1/20 0.39
ELANE P08246 1/20 0.39
CTRB1 P17538 1/20 0.39
RHOA P61586 1/20 0.39
USP2 O75604 1/20 0.38
PKM P14618 1/20 0.38
SLC6A3 Q01959 1/20 0.38
LMNA P02545 1/20 0.37
MCHR1 Q99705 1/20 0.37
OPRK1 P41145 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873654 0.84 SHMT2 (0.44) ALDH1A1KDM4EMEN1KMT2AUSP2
SCHEMBL5873616 0.73 KDM4E (0.61) ALDH1A1KDM4EMEN1KMT2AF2
SCHEMBL5873653 0.72 MCHR1 (0.73) MCHR1
SCHEMBL31114157 0.70 HTT (0.61) ALDH1A1HTTSLC6A3LMNAOPRK1
SCHEMBL5873479 0.69 ALDH1A1 (0.54) ALDH1A1RHOALMNAMCHR1
SCHEMBL25855694 0.68 MAPT (0.51) ALDH1A1MEN1KMT2ALMNAMCHR1
SCHEMBL11894860 0.66 EIF4A1 (0.53) ALDH1A1KDM4EMEN1KMT2APKM
SCHEMBL25196170 0.66 MEN1 (0.46) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL6558013 0.66 ALDH1A1 (0.49) ALDH1A1LMNAMCHR1MAPTSMN1; SMN2
SCHEMBL2906892 0.65 ALDH1A1 (0.60) ALDH1A1MEN1KMT2AF2PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084156-B2 2-Aminoquinoline compounds MERCK & CO., INC. (US) 2006-08-01 US disclosed
US-20050026915-A1 2-Aminoquinoline compounds MERCK SHARP & DOHME CORP. 2005-02-03 US disclosed
EP-1450801-A2 2-AMINOQUINOLINE COMPOUNDS Merck & Co., Inc. (US) 2004-09-01 EP disclosed
WO-2003045313-A2 2-AMINOQUINOLINE COMPOUNDS MERCK & CO. INC. (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026915-A1 2-Aminoquinoline compounds MCHR1, MCHR2, MC5R ALDH1A1 460/4885HTT 61/4885KDM4E 822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.